Our visit today at Dana-Farber went well. The doctors have identified a mutated gene that is driving the cancer cells. This gene is a rare occurrence, showing up in only about 1-2% of lung cancer patients. The good news is, this is one of the four gene mutations for which they have discovered a targeted therapy. At this time Stuart’s treatment will involve taking two crizotinib pills daily. As long as the crizotinib continues to work (i.e., the cancer doesn’t mutate), Stu can avoid having to undergo traditional chemotherapy via infusions.
Therefore, our hope is that not only does the crizotinib do what it is supposed to do (with few side effects), but that it does so for a long time! Doctors are optimistic that he will start to see results in 1-2 weeks. He will continue to be monitored with blood workups, CT scans, and eventually another PET scan.
Please continue to send your love, support, and positive energy as we begin the next part of this journey.